FMC shares came under pressure in premarket trading on Tuesday.

Following the publication of the quarterly results, they fell by around three percent to €42.10 on the Tradegate trading platform compared to Monday's Xetra close. In regular trading, this would represent a low since the end of April.

A severe flu season and increased mortality have recently weighed on the dialysis provider's operating result (EBIT), wrote analyst James Vane-Tempest of investment firm Jefferies in an initial reaction. The operating result fell short of market expectations by 1%./bek/mis

-----------------------dpa-AFX Broker - the trader news from dpa-AFX-----------------------